Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CROSS II
NL-OMON20325Active, not recruiting
- Sponsor
- N/A
- Start
- Mar 2004
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of paclitaxel and carboplatin in esophageal cancer (2 arms), sponsored by N/A. Started Mar 2004; status: active, not recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NL-OMON20325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20325.